Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Stroke. 2008 Oct 23;40(2):663. doi: 10.1161/STROKEAHA.108.525352

Table 3.

Onset-to-Treatment and Arrival-to-Treatment Times in Patients Who Received Standard of Care tPA Compared With Patients Participating in Clinical Studies That Either Required Prelytic or Postlytic Enrollment

Variable Not Enrolled Studies With Postlytic Enrollment Studies With Prelytic Enrollment P Value
(N=225) 46/65 (70.8%) 19/65 (29.2%)
Onset-to-arrival, median (range) 66 (17–137) 60 (25–120) 59 (15–116) NS
Onset-to-treatment, median (range) 135 (64–180) 126 (64–180) 128 (92–178) NS
Arrival-to-treatment, median (range) 62 (20–131) 59 (23–135) 72 (52–111) 0.027*
0.56
0.028
*

Comparison of nonenrolled patients with patients that were enrolled in prelytic studies.

Comparison of nonenrolled patients with patients that were enrolled in postlytic studies.

Comparison of patients enrolled in pre- versus postlytic studies.

NS indicates nonsignificant.